Panacos Intangible Assets from 2010 to 2026
| PANC Stock | USD 0.0001 0.00 0.00% |
Intangible Assets | First Reported 2010-12-31 | Previous Quarter 358.2 K | Current Value 340.3 K | Quarterly Volatility 849.8 K |
Check Panacos Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Panacos Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Total Revenue of 153.9 K or Research Development of 21.1 M, as well as many indicators such as Price To Sales Ratio of 22.04, Dividend Yield of 0.0 or PTB Ratio of 0.0799. Panacos financial statements analysis is a perfect complement when working with Panacos Pharmaceuticals Valuation or Volatility modules.
Panacos | Intangible Assets | Build AI portfolio with Panacos Stock |
Analyzing Panacos Pharmaceuticals's Intangible Assets over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Intangible Assets has evolved provides context for assessing Panacos Pharmaceuticals's current valuation and future prospects.
Latest Panacos Pharmaceuticals' Intangible Assets Growth Pattern
Below is the plot of the Intangible Assets of Panacos Pharmaceuticals over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. Panacos Pharmaceuticals' Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Panacos Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Intangible Assets | 10 Years Trend |
|
Intangible Assets |
| Timeline |
Panacos Intangible Assets Regression Statistics
| Arithmetic Mean | 597,970 | |
| Geometric Mean | 448,189 | |
| Coefficient Of Variation | 142.11 | |
| Mean Deviation | 387,886 | |
| Median | 398,000 | |
| Standard Deviation | 849,784 | |
| Sample Variance | 722.1B | |
| Range | 3.6M | |
| R-Value | (0.42) | |
| Mean Square Error | 635.5B | |
| R-Squared | 0.17 | |
| Significance | 0.09 | |
| Slope | (70,383) | |
| Total Sum of Squares | 11.6T |
Panacos Intangible Assets History
About Panacos Pharmaceuticals Financial Statements
Panacos Pharmaceuticals stakeholders use historical fundamental indicators, such as Panacos Pharmaceuticals' Intangible Assets, to determine how well the company is positioned to perform in the future. Although Panacos Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Panacos Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Panacos Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Panacos Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Intangible Assets | 358.2 K | 340.3 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Panacos Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Panacos Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Panacos Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Panacos Pharmaceuticals Stock:Check out the analysis of Panacos Pharmaceuticals Correlation against competitors. For information on how to trade Panacos Stock refer to our How to Trade Panacos Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Will Biotechnology sector continue expanding? Could Panacos diversify its offerings? Factors like these will boost the valuation of Panacos Pharmaceuticals. Anticipated expansion of Panacos directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Panacos Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.01) | Revenue Per Share | Quarterly Revenue Growth (0.20) | Return On Assets | Return On Equity |
Understanding Panacos Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Panacos's accounting equity. The concept of intrinsic value - what Panacos Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Panacos Pharmaceuticals' price substantially above or below its fundamental value.
It's important to distinguish between Panacos Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Panacos Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Panacos Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.